Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) |
Amyotrophic Lateral Sclerosis (ALS) | Phase2 | United States | NCT06643481 |
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
Spinal Muscular Atrophy (SMA) | Greece Ireland Israel Korea, Republic of Poland Portugal Romania Russian Federation Taiwan United States View All |
NCT04174157 | |
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy |
Atypical Hemolytic Uremic Syndrome | Phase3 | Austria Brazil China Czechia Greece India Japan Korea, Republic of Slovakia Slovenia Taiwan United Kingdom United States View All |
NCT04889430 |
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis |
Moderate-to-severe Plaque Psoriasis | Russian Federation | NCT06142357 | |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Austria Belgium Brazil Bulgaria Chile China Colombia Croatia Denmark Georgia Guatemala Hong Kong India Ireland Israel Italy Jordan Latvia Lebanon Lithuania Malaysia Mexico Netherlands Poland Saudi Arabia Slovakia Spain Switzerland Taiwan Turkey United Arab Emirates United Kingdom United States View All |
NCT05147220 |
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction |
Plaque, Atherosclerotic | Phase4 | China | NCT06372925 |
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease |
Sjögrens Disease, Systemic Lupus Erythematosus, Rheumatoid Arthritis | Phase2 | Canada Czechia Hungary Italy Poland Spain United States View All |
NCT06293365 |
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 | Argentina Austria Colombia Czechia Greece Guatemala Hungary Italy Mexico Panama Portugal Romania South Africa Spain View All |
NCT05562466 |
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients |
Multiple Sclerosis, Relapsing-Remitting | Italy | NCT06345157 | |
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). |
Fascioliasis | Phase4 | Colombia Egypt Peru Vietnam View All |
NCT04230148 |